Henry Schein, Inc. (HSIC) – What Are Brokerages Saying About This Stock?

Shares of Henry Schein, Inc. (NASDAQ:HSIC) have been assigned a consensus rating of “Moderate Buy” from the fifteen analysts that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, five have given a hold rating and nine have issued a buy rating on the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $93.27.

HSIC has been the subject of several recent analyst reports. BTIG Research increased their price objective on shares of Henry Schein from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, August 19th. Barclays restated an “overweight” rating and issued a $100.00 price objective (up from $86.00) on shares of Henry Schein in a report on Thursday, August 6th. UBS Group set a $94.00 price objective on Henry Schein and gave the company a “neutral” rating in a research report on Wednesday, August 5th. Leerink Partners set a $92.00 target price on shares of Henry Schein and gave the stock a “market perform” rating in a report on Wednesday, October 14th. Finally, Piper Sandler upped their price target on Henry Schein from $91.00 to $95.00 and gave the company an “overweight” rating in a research report on Wednesday, July 29th.

Institutional Investors Weigh In On Henry Schein

Large investors have recently made changes to their positions in the company. Parallel Advisors LLC raised its position in Henry Schein by 12.7% during the first quarter. Parallel Advisors LLC now owns 1,314 shares of the company’s stock valued at $97,000 after acquiring an additional 148 shares in the last quarter. Mufg Securities Americas Inc. grew its position in Henry Schein by 5.3% in the second quarter. Mufg Securities Americas Inc. now owns 2,917 shares of the company’s stock worth $244,000 after acquiring an additional 148 shares in the last quarter. New Mexico Educational Retirement Board increased its stake in shares of Henry Schein by 4.2% during the 2nd quarter. New Mexico Educational Retirement Board now owns 4,950 shares of the company’s stock worth $413,000 after purchasing an additional 200 shares during the last quarter. Czech National Bank increased its stake in shares of Henry Schein by 1.1% during the 2nd quarter. Czech National Bank now owns 27,561 shares of the company’s stock worth $2,302,000 after purchasing an additional 308 shares during the last quarter. Finally, Blackhawk Capital Partners LLC raised its holdings in shares of Henry Schein by 8.7% during the 1st quarter. Blackhawk Capital Partners LLC now owns 4,665 shares of the company’s stock valued at $344,000 after purchasing an additional 374 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Price Performance

Henry Schein stock opened at $84.25 on Friday. The firm has a 50-day moving average price of $86.74 and a two-hundred day moving average price of $80.97. Henry Schein has a 52-week low of $62.15 and a 52-week high of $92.18.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $1.27 EPS for the quarter, beating the consensus estimate of $1.24 by $0.03. The firm had revenue of $3.46 billion during the quarter, compared to analyst estimates of $3.37 billion. During the same quarter in the previous year, the business posted $1.10 EPS. Henry Schein’s revenue for the quarter was up 6.7% compared to the same quarter last year. Henry Schein has set its FY 2026 guidance at 5.290-5.390 EPS. Sell-side analysts anticipate that Henry Schein will post 5.36 EPS for the current year.

About Henry Schein

Henry Schein, Inc (NASDAQ: HSIC) is a global provider of healthcare products and services serving dental and medical professionals, as well as veterinary practices and laboratories. The company distributes consumable supplies, equipment, pharmaceuticals, vaccines, and other products used in clinical and practice-management settings.

In addition to product distribution, Henry Schein provides technology solutions and value-added services designed to support clinical workflows, electronic health records, practice management, procurement, equipment installation, and technical support.